Diamond Biotechnology Co., Ltd (6815.TWO)
TWD 62.1
(3.5%)
TWD 62.1
(3.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 40.9 Million | 157.53 Million | 5.64 Million | 71.16 Million | 23.15 Million |
| Net Income | 58.33 Million | 41.82 Million | 52.05 Million | 13.5 Million | 44.18 Million |
| Depreciation & Amortization | 50.31 Million | 53.47 Million | 58.17 Million | 54.82 Million | 31.59 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -53.39 Million | 66.09 Million | -101.31 Million | 11.51 Million | -59.6 Million |
| Other non-cash items | 6.82 Million | 3.31 Million | 122 Thousand | 2.21 Million | 6.99 Million |
| Investing Cash Flow | -196.31 Million | -132.56 Million | -52.11 Million | -26.84 Million | -31.76 Million |
| Investments in PPE | -196.62 Million | -72.96 Million | -24.89 Million | -56.96 Million | -16.55 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | -2.76 Million | -2 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 313 Thousand | -62.55 Million | -28.7 Million | -2.83 Million | -15.2 Million |
| Financing Cash Flow | 135.46 Million | 22.29 Million | 35.32 Million | -38.46 Million | 23.02 Million |
| Debt repayment | -161.08 Million | -50.6 Million | -61.62 Million | -16.22 Million | -9.05 Million |
| Dividends payments | -3.02 Million | -3.81 Million | -994 Thousand | -29.28 Million | -36.3 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 50 Million |
| Other Financing Activities | 446 Thousand | 520 Thousand | 35 Million | -2 Million | -618 Thousand |
| Accounts receivables | -48.89 Million | 39.48 Million | -86.77 Million | 22.5 Million | -31.89 Million |
| Accounts payables | -9.8 Million | - | - | - | - |
| Inventory | -1.91 Million | 2.2 Million | -14 Million | -13.02 Million | -26.87 Million |
| Other working capital | 5.65 Million | 11.07 Million | -13.7 Million | 5.81 Million | -843 Thousand |
| Cash at beginning of period | 98.47 Million | 51.2 Million | 62.35 Million | 56.52 Million | 42 Million |
| Cash at end of period | 78.51 Million | 98.47 Million | 51.2 Million | 62.35 Million | 56.52 Million |
| Capital Expenditure | -196.62 Million | -72.96 Million | -24.89 Million | -56.96 Million | -16.55 Million |
| Effect of forex changes on cash | -12 Thousand | 7000.00 | -4000.00 | -28 Thousand | 108 Thousand |
| Net cash flow / Change in cash | -19.95 Million | 47.26 Million | -11.14 Million | 5.82 Million | 14.52 Million |
| Free Cash Flow | -155.72 Million | 84.57 Million | -19.25 Million | 14.19 Million | 6.59 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25 Million | 25 Million | 8.48 Million | 58.33 Million | 8.48 Million | 14.88 Million |
| Depreciation & Amortization | 7.82 Million | 7.82 Million | 12.41 Million | 50.31 Million | 12.41 Million | 12.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -70.99 Million | -70.99 Million | -5.03 Million | -53.39 Million | -5.03 Million | -17.55 Million |
| Other non-cash items | 12.61 Million | 12.61 Million | 1.07 Million | 6.82 Million | 1.07 Million | -6.46 Million |
| Investing Cash Flow | 4.82 Million | 4.82 Million | -9.07 Million | -196.31 Million | -9.07 Million | -89.07 Million |
| Investments in PPE | -10.57 Million | -11.26 Million | -7.67 Million | -196.62 Million | -7.67 Million | -90.64 Million |
| Acquisitions | 28.04 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 15.39 Million | 16.08 Million | -1.4 Million | 313 Thousand | -1.4 Million | 1.56 Million |
| Financing Cash Flow | 93.5 Million | 93.5 Million | -697.5 Thousand | 135.46 Million | -697.5 Thousand | 68.42 Million |
| Debt repayment | -39.22 Million | - | - | -161.08 Million | - | - |
| Dividends payments | - | - | -1.51 Million | -3.02 Million | -1.51 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 221 Million | - | - | - | - | - |
| Other Financing Activities | 93.5 Million | 93.5 Million | 814 Thousand | 446 Thousand | 814 Thousand | 68.42 Million |
| Accounts receivables | -31.6 Million | -31.6 Million | -12.04 Million | -48.89 Million | -12.04 Million | -12.4 Million |
| Accounts payables | -6.63 Million | - | - | - | - | - |
| Inventory | -4.66 Million | -4.66 Million | -1.7 Million | -1.91 Million | -1.7 Million | 743 Thousand |
| Other working capital | -34.72 Million | -34.72 Million | 8.71 Million | 5.65 Million | 8.71 Million | -5.88 Million |
| Cash at beginning of period | 78.51 Million | - | - | 98.47 Million | - | - |
| Cash at end of period | 72.81 Million | 72.81 Million | 7.16 Million | 78.51 Million | 7.16 Million | -17.14 Million |
| Capital Expenditure | -10.57 Million | -11.26 Million | -7.67 Million | -196.62 Million | -7.67 Million | -90.64 Million |
| Effect of forex changes on cash | 46 Thousand | 46 Thousand | -500.00 | -12 Thousand | -500.00 | -5500.00 |
| Net cash flow / Change in cash | -5.7 Million | 72.81 Million | 7.16 Million | -19.95 Million | 7.16 Million | -17.14 Million |
| Free Cash Flow | -36.13 Million | -36.82 Million | 9.26 Million | -155.72 Million | 9.26 Million | -87.12 Million |
ADANIPORTS
BABA
MSS
002059
SHASF
8098